Early High-Dose Erythropoietin and Cognitive Functions of School-Aged Children Born Very Preterm
This study found no evidence for a positive association between prophylactic early high-dose rhEpo administration and long-term neurodevelopmental outcomes after very preterm birth. These results suggest that a comprehensive approach, including pharmacological and nonpharmacological prevention and intervention strategies, is needed to support these children's neurodevelopmental outcome.
Authors
- Alexandra Stöckli
- Hans Ulrich Bucher (ORCID: https://orcid.org/0000-0003-4458-1161)
- Vera Disselhoff
- Flavia M. Wehrle (ORCID: https://orcid.org/0000-0001-5992-0424)
- Ulrike Held (ORCID: https://orcid.org/0000-0003-3105-5840)
- Maria Chiara Liverani (ORCID: https://orcid.org/0000-0002-8021-9760)
- Ruth Tuura (ORCID: https://orcid.org/0000-0001-5932-7786)
- Giancarlo Natalucci (ORCID: https://orcid.org/0000-0003-0225-2431)
- Cornelia Franziska Hagmann (ORCID: https://orcid.org/0000-0003-2647-9809)
- Cristina Borradori-Tolsa
- Barbara Schnider (ORCID: https://orcid.org/0000-0002-6574-1868)
- Petra S. Hüppi (ORCID: https://orcid.org/0000-0002-7383-6648)
- Beatrice Latal (ORCID: https://orcid.org/0000-0003-1309-4790)
- Jean‐Claude Fauchère (ORCID: https://orcid.org/0000-0001-8158-7410)
- Mina Toma
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
- University Hospital of Geneva (CH)
- University Children's Hospital Zurich (CH)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.30043
- Citations
- 5
- Primary Topic
- Neonatal and fetal brain pathology
- Type
- article
- Field-Weighted Citation Impact
- 5.55